TABLE 1.
Whole-genome sequencing data from DAP-evolved HOU503 isolatesa
| Isolate | MIC (μg/mL)a |
Mutation(s) inb: |
Additional mutationsb,c | ||||||
|---|---|---|---|---|---|---|---|---|---|
| DAP | FOS | pgsA | cls | gdpD | CDP-AP | murF | Pyruvate carboxylase | ||
| FT1 | |||||||||
| D1 | 64 | 128 | H215R and R211L | +4 | |||||
| D2 | 64 | 128 | H215R and R211L | +4 | |||||
| D3 | 64 | 128 | H215R and R211L | +4 | |||||
| D4 | 64 | 128 | −62 | S323R | +6 | ||||
| D5 | 64 | 128 | −62 | S323R | +4 | ||||
| D6 | 64 | 170.7 | A20D | +4 | |||||
| D7 | 26.7 | 128 | A98D | +3 | |||||
| D8 | 32 | 128 | +5 | ||||||
| D9 | 16 | 128 | A20D | +2 | |||||
| D10 | 64 | 128 | −45 | Q1073* | +7 | ||||
| D11 | 32 | 128 | A20D | Q1073* | +6 | ||||
| D12 | 9.3 | 128 | V85F | Q1073* | +3 | ||||
| D13 | 32 | 170.7 | R211L | +4 | |||||
| D14 | 13.3 | 128 | −62 | +4 | |||||
| D15 | 32 | 213.3 | H215R | +3 | |||||
| FT2 | |||||||||
| D16 | 32 | 128 | T70P | +2 | |||||
| D17 | 26.7 | 128 | T70P | +3 | |||||
| D18 | 13.3 | 64 | T70P | +2 | |||||
| D19 | 42.7 | 64 | R211Q | +3 | |||||
| D20 | 32 | 128 | R211Q | +3 | |||||
| D21 | 32 | 64 | R211Q | +3 | |||||
| D22 | >128 | 128 | L93H | −62 | +3 | ||||
| D23 | >128 | 128 | L93H | −62 | +3 | ||||
| D24 | 128 | 128 | L93H | −62 | +4 | ||||
| D25 | 21.3 | 128 | H215R | +2 | |||||
| D26 | 16 | 64 | H215R | +2 | |||||
| D27 | 16 | 64 | H215R | +2 | |||||
| D28 | 64 | 128 | −62 | +3 | |||||
| D29 | 64 | 128 | −62 | +3 | |||||
| D30 | 64 | 64 | −62 | +3 | |||||
The MICs reported were averaged over three biological replicates. The HOU503 (LiaRW73C LiaST120A) DAP MIC was 3 μg/mL, and the FOS MIC was 128 μg/mL. * indicate a stop codon.
The selected mutations shown do not include those observed in the no-drug control isolates or initial starting ancestor.
The “Additional mutations” column includes occurrences of van operon (vanRSHAXYZ) loss. D5 and D6 retained one van operon copy, while other isolates lost both copies.